Works by Huang, Si-Man

Results: 7

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 159, doi. 10.2147/OTT.S336715

By:

Zhang, Lei-Si;
Wang, Jun;
Xu, Ming-Zhu;
Wu, Tian-Mei;
Huang, Si-Man;
Cao, Han-Yu;
Sun, Ai-Ning;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Article

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.

Published in:

2023

By:

Huang, Si‐Man;
Wan, Chao‐Ling;
Cao, Han‐Yu;
Li, Yan‐Yan;
Qian, Chong‐Sheng;
Zhou, Hai‐Xia;
Xu, Ming‐Zhu;
Hu, Xiao‐Hui;
Dai, Lan;
Dai, Hai‐Ping;
Xue, Sheng‐Li

Publication type:

Case Study

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report.

Published in:

2023

By:

Huang, Si‐Man;
Tao, Tao;
Wan, Chao‐Ling;
Wu, Tian‐Mei;
Cao, Han‐Yu;
Qiu, Yan;
Shen, Xiang‐Dong;
Wang, Bin‐Ru;
Ge, Shuai‐Shuai;
Li, Yan‐Yan;
Zhang, Tong‐Tong;
Wu, Bing;
Xue, Sheng‐Li

Publication type:

Case Study

Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.

Published in:

Annals of Hematology, 2024, v. 103, n. 12, p. 6003, doi. 10.1007/s00277-024-06137-5

By:

Liu, Fang-Tong;
Wan, Chao-Ling;
Huang, Yuan-Hong;
Cao, Han-Yu;
Lyu, Xiao-Yu;
Wang, Zi-Hao;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Zhang, Yang;
Xue, Sheng-Li

Publication type:

Article

Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.

Published in:

Annals of Hematology, 2023, v. 102, n. 9, p. 2397, doi. 10.1007/s00277-023-05236-z

By:

Tan, Kai-Wen;
Zhu, Yi-Yan;
Qiu, Qiao-Cheng;
Wang, Man;
Shen, Hong-Jie;
Huang, Si-Man;
Cao, Han-Yu;
Wan, Chao-Ling;
Li, Yan-Yan;
Dai, Hai-Ping;
Xue, Sheng-Li

Publication type:

Article

Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias.

Published in:

Hematology, 2023, v. 28, n. 1, p. 1, doi. 10.1080/16078454.2023.2237790

By:

Zou, Jing-Ying;
Huang, Si-Man;
Zhoub, Hai-Xia;
Xu, Ming-Zhu;
Sun, Ai-Ning;
Wu, De-Pei;
Xue, Sheng-Li;
Zhang, Tong-Tong

Publication type:

Article

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.

Published in:

2024

By:

Wan, Chao-Ling;
Liu, Yu-Qing;
Liu, Fang-Tong;
Huang, Yuan-Hong;
Cao, Han-Yu;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Wang, Miao;
Liu, Mei-Jing;
Wang, Zi-Hao;
Li, Zheng;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Letter